Initially designed for paediatric and rare diseases, the Atom5TM platform can enhance compliance and has the potential to improve the outcomes of any clinical trial. Its data-driven, decentralised platform allows for clinical studies to be done anytime, anywhere, allowing patients and their caregivers to participate in research from the comfort of their own homes.

Our therapy areas

We’re involved in projects across many areas including Rare Disease, Paediatrics, Ataxia and Neurodegenerative conditions, and provide support for R&D of more patient-centric clinical outcomes through initiatives such as our Patient Group Accelerator Programme.

Our success stories

Success Story:
Feasibility of facial expression analysis


Success Story:
 ePROs for Traumatic Brain Injury Patients


Success Story:
Digital Tools for Outcome Measures in Gaucher Disease


Success Story:
Remote Patient Monitoring for Oncology Patients

Success Story:
ePROs and eConsent for Long COVID (TLC)


Our Credentials

21 CFR Part 11 compliant
Cyber Essentials Plus
ISO 13485
ISO 27001
ePrivacy App

Our Latest Paper

The Symptom Burden Questionnaire™ for Long COVID